4.6 Article

Molecular Taxonomic Evidence for Two Distinct Genotypes of Mycobacterium yongonense via Genome-Based Phylogenetic Analysis

Journal

PLOS ONE
Volume 11, Issue 3, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0152703

Keywords

-

Funding

  1. Korean Healthcare Technology R&D project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [HI13C15620000]
  2. National Research Foundation of Korea [NRF-2014R1A1A2004008]

Ask authors/readers for more resources

Recently, we introduced a distinct Mycobacterium intracellulare INT-5 genotype, distantly related to other genotypes of M. intracellulare (INT-1 to -4). The aim of this study is to determine the exact taxonomic status of the M. intracellulare INT-5 genotype via genome-based phylogenetic analysis. To this end, genome sequences of the two INT-5 strains, MOTT-H4Y and MOTT-36Y were compared with M. intracellulare ATCC 13950(T) and Mycobacterium yongonense DSM 45126(T). Our phylogenetic analysis based on complete genome sequences, multi-locus sequence typing (MLST) of 35 target genes, and single nucleotide polymorphism (SNP) analysis indicated that the two INT-5 strains were more closely related to M. yongonense DSM 45126T than the M. intracellulare strains. These results suggest their taxonomic transfer from M. intracellulare into M. yongonense. Finally, we selected 5 target genes (argH, dnaA, deaD, hsp65, and recF) and used SNPs for the identification of M. yongonese strains from other M. avium complex (MAC) strains. The application of the SNP analysis to 14 MAC clinical isolates enabled the selective identification of 4 M. yongonense clinical isolates from the other MACs. In conclusion, our genome-based phylogenetic analysis showed that the taxonomic status of two INT-5 strains, MOTT-H4Y and MOTT-36Y should be revised into M. yongonense. Our results also suggest that M. yongonense could be divided into 2 distinct genotypes (the Type I genotype with the M. parascrofulaceum rpoB gene and the Type II genotype with the M. intracellulare rpoB gene) depending on the presence of the lateral gene transfer of rpoB from M. parascrofulaceum.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Naturally Occurring Hepatitis B Virus Mutations Leading to Endoplasmic Reticulum Stress and Their Contribution to the Progression of Hepatocellular Carcinoma

Yu-Min Choi, So-Young Lee, Bum-Joon Kim

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Oncology

Heat-killed Mycobacterium paragordonae therapy exerts an anti-cancer immune response via enhanced immune cell mediated oncolytic activity in xenograft mice model

So-Young Lee, Soo-Bin Yang, Yu-Min Choi, Song-Ji Oh, Byung-Jun Kim, Yoon-Hoh Kook, Bum-Joon Kim

CANCER LETTERS (2020)

Article Immunology

A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect via Mitochondrial DNA Stress-Dependent Type I Interferon Production

Yu-Min Choi, Hong Kim, Seoung-Ae Lee, So-Young Lee, Bum-Joon Kim

FRONTIERS IN IMMUNOLOGY (2020)

Article Microbiology

Diagnostic Potential of IgG and IgA Responses toMycobacterium tuberculosisAntigens for Discrimination among Active Tuberculosis, Latent Tuberculosis Infection, and Non-Infected Individuals

Ji Yeon Lee, Byoung-Jun Kim, Hyeon-Kyoung Koo, Junghyun Kim, Jee-min Kim, Yoon-Hoh Kook, Bum-Joon Kim

MICROORGANISMS (2020)

Article Oncology

A Hepatitis B Virus-Derived Peptide Exerts an Anticancer Effect via TNF/iNOS-producing Dendritic Cells in Tumor-Bearing Mouse Model

Soo-Bin Yang, Mi-Hyun Lee, Bo-Ram Kim, Yu-Min Choi, Bum-Joon Kim

Summary: Recent studies have shown that a tumor necrosis factor (TNF)/inducible nitric oxide synthase (iNOS)-producing dendritic cell (Tip-DC) may activate CD8+ T cells in tumor microenvironments. The development of a new immunotherapeutic agent, such as Poly6, has gained attention in enhancing Tip-DC activity for anticancer immune response. Poly6 treatment has demonstrated potential in activating an antitumor immune response in mice, suggesting its use as an adjuvant for cancer immunotherapy.

CANCERS (2021)

Article Medicine, General & Internal

Usefulness of the IgA and IgG Responses to Macrophage Migration Inhibitory Factor for the Diagnosis of Tuberculosis

Ji Yeon Lee, Byoung-Jun Kim, Jee-min Kim, Junghyun Kim, Joon-Sung Joh, Ina Jeong, Yoon-Hoh Kook, Bum-Joon Kim

DIAGNOSTICS (2020)

Article Immunology

A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation

Hyein Jeong, Yu-Min Choi, Hyejun Seo, Bum-Joon Kim

Summary: In this study, a novel DNA vaccine candidate against SARS-CoV-2 called W4P-RBD was developed and shown to induce robust humoral and cell-mediated immune responses in vaccinated mice, suggesting its potential as a protective measure against SARS-CoV-2 infection.

FRONTIERS IN IMMUNOLOGY (2021)

Article Microbiology

rt269I Type of Hepatitis B Virus (HBV) Polymerase versus rt269L Is More Prone to Mutations within HBV Genome in Chronic Patients Infected with Genotype C2: Evidence from Analysis of Full HBV Genotype C2 Genome

Hyein Jeong, Dong Hyun Kim, Yu-Min Choi, HyeLim Choi, Donghyun Kim, Bum-Joon Kim

Summary: The study showed that HBV rt269I type is more prone to overall genome mutations compared to rt269L type in genotype C2 infections, especially in the Pol region and MHR, leading to lower HBV DNA replication, HBsAg and HBeAg secretion, potential NAr variants and HCC. Furthermore, rt269L type may contribute to liver disease progression through immune escape or enhanced persistent infection in chronic patients of genotype C2.

MICROORGANISMS (2021)

Article Virology

A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner

Yu-Min Choi, Hyein Jeong, Uni Park, Nam-Hyuk Cho, Bum-Joon Kim

Summary: Poly6, a hepatitis B virus hexamer peptide, shows an anti-SARS-CoV-2 effect with an estimated inhibitory concentration of 2.617 mu M in human bronchial epithelial cells, mediated through an IFN-I dependent manner. It also inhibits IL-6 production enhanced by SARS-CoV-2 in an IFN-I dependent manner, indicating its potential as a COVID-19 drug with potent antiviral and anti-inflammatory activities.

VIRUSES-BASEL (2021)

Article Immunology

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections

Byoung-Jun Kim, Hyein Jeong, Hyejun Seo, Mi-Hyun Lee, Hyun Mu Shin, Bum-Joon Kim

Summary: This study developed a novel vaccine candidate that induced strong immune responses in mice, showing potential efficacy against SARS-CoV-2 infections.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model

Hyein Jeong, So-Young Lee, Hyejun Seo, Bum-Joon Kim

Summary: The rSmeg-hMIF-hIL-7 vaccine demonstrated strong anti-tumor immune response in mice by inhibiting MIF-dependent tumorigenesis promotion and enhancing cytotoxic T cell recruitment into tumor microenvironments. It also showed enhanced anticancer effect with immune checkpoint inhibitors, suggesting its potential as an adjuvant for cancer immunotherapy. This study is the first to demonstrate the anticancer potential of an immunotherapeutic vaccine targeting immune response against MIF.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Microbiology

COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity

Mi-Hyun Lee, Bum-Joon Kim

Summary: This review presents the current status of COVID-19 vaccine development based on recombinant viral and bacterial delivery systems, and discusses the use of licensed live vaccines to prevent COVID-19 infections.

JOURNAL OF MICROBIOLOGY (2022)

Article Oncology

Potential of Mycobacterium tuberculosis chorismate mutase (Rv1885c) as a novel TLR4-mediated adjuvant for dendritic cell-based cancer immunotherapy

Hyein Jeong, So-Young Lee, Hyejun Seo, Dong Hyun Kinnar, Duhyung Lee, Bum-Joon Kim

Summary: The study demonstrates the potential of TBCM as an immunoadjuvant for DC-based cancer immunotherapy. TBCM can activate DCs and induce a strong anticancer immune response, inhibiting tumor growth and metastasis through functional cytotoxic T lymphocyte-mediated oncolytic activity and inhibition of cancer proliferation- and metastasis-related genes.

ONCOIMMUNOLOGY (2022)

No Data Available